AIC
HAE icon

Aurora Investment Counsel’s Haemonetics HAE Stock Holding History

Aurora Investment Counsel’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.22M Buy
+21,595
New +$1.41M 0.68% 80
2022
Q4 		– Sell
-22,059
Closed -$1.63M – 115
2022
Q3 		$1.63M Sell
22,059
-9,466
-30% -$680K 1.24% 14
2022
Q2 		$2.06M Buy
31,525
+73
+0.2% +$4.32K 1.48% 3
2022
Q1 		$1.99M Sell
31,452
-697
-2% -$37.9K 1.27% 5
2021
Q4 		$1.71M Buy
+32,149
New +$1.96M 1.01% 30

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aurora Investment Counsel's HAE Position: Q1 2026 in Review

Aurora Investment Counsel opened a new position in Haemonetics (HAE) in Q1 2026: 21,595 shares worth $1.22M. The stake represents 0.68% of the portfolio and ranks #80 among its holdings. This is a return to the name: Aurora Investment Counsel previously reported a position in HAE as recently as Q3 2022.

Aurora Investment Counsel first reported a position in HAE in Q4 2021 and has held it in 5 quarters since. The position peaked at $2.06M in Q2 2022. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Aurora Investment Counsel held 21,595 shares of Haemonetics worth $1.22M as of Q1 2026.
  • Haemonetics was a new Aurora Investment Counsel position in Q1 2026.
  • Haemonetics made up 0.68% of Aurora Investment Counsel's portfolio in Q1 2026, its #80 holding.
  • Aurora Investment Counsel first reported a position in Haemonetics in Q4 2021 and has held it in 5 quarters since.
  • Aurora Investment Counsel's Haemonetics position peaked at $2.06M in Q2 2022.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Aurora Investment Counsel's 13F filing for Q1 2026, filed 6 May 2026.